Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-13 5:40 pm Sale | 13G | MAXEON SOLAR TECHNOLOGIES LTD MAXN | Cowen Financial Products LLC | 175,000 0.000% | -2,600,000 (-93.69%) | View |
| 2024-11-13 5:36 pm Sale | 13G | LL FLOORING HOLDINGS, INC. LLFLQ | Cowen Financial Products LLC | 0 0.000% | -1,622,000 (Position Closed) | View |
| 2024-11-13 4:40 pm Sale | 13G | Avidity Biosciences Inc. RNA | Cowen Financial Products LLC | 0 0.000% | -5,629,103 (Position Closed) | View |
| 2024-11-13 3:49 pm Sale | 13G | ADICET BIO INC ACET | Cowen Financial Products LLC | 0 0.000% | -2,715,278 (Position Closed) | View |
| 2024-06-14 09:04 am Purchase | 13G | MAXEON SOLAR TECHNOLOGIES LTD MAXN | Cowen Financial Products LLC | 2,775,000 5.050% | 2,775,000 (New Position) | View |
| 2024-05-23 10:47 am Sale | 13G | CANNA-GLOBAL ACQUISITION CORP CNGL | Cowen Financial Products LLC | 195,000 9.890% | -5,000 (-2.50%) | View |
| 2024-02-26 10:38 am Purchase | 13G | Stoke Therapeutics Inc. STOK | Cowen Financial Products LLC | 3,721,659 8.300% | 1,445,553 (+63.51%) | View |
| 2024-02-26 10:36 am Purchase | 13G | Stoke Therapeutics Inc. STOK | Cowen Financial Products LLC | 2,276,106 5.770% | 1,028,029 (+82.37%) | View |
| 2024-02-02 3:17 pm Sale | 13G | DTRT Health Acquisition Corp. DTRT | Cowen Financial Products LLC | 0 0.000% | -224,845 (Position Closed) | View |
| 2024-02-02 3:16 pm Sale | 13G | EXAGEN INC. XGN | Cowen Financial Products LLC | 898,630 5.270% | -67,392 (-6.98%) | View |
| 2024-02-02 12:46 pm Sale | 13G | VEXT SCIENCE INC VEXTF | Cowen Financial Products LLC | 0 0.000% | -4,856,256 (Position Closed) | View |
| 2024-02-02 12:44 pm Sale | 13G | Verano Holdings Corp. VRNOF | Cowen Financial Products LLC | 0 0.000% | -16,497,443 (Position Closed) | View |
| 2024-02-02 12:43 pm Sale | 13G | Trulieve Cannabis Corp. TRUL | Cowen Financial Products LLC | 0 0.000% | -11,148,292 (Position Closed) | View |
| 2024-02-02 12:40 pm Purchase | 13G | Tarsus Pharmaceuticals Inc. TARS | Cowen Financial Products LLC | 1,911,399 5.770% | 512,416 (+36.63%) | View |
| 2024-02-02 12:38 pm Sale | 13G | SYLVAMO CORP COM SLVM | Cowen Financial Products LLC | 0 0.000% | -2,150,000 (Position Closed) | View |
| 2024-02-02 12:36 pm Sale | 13G | SOL GLOBAL INVTS CORP COM SOLCF | Cowen Financial Products LLC | 0 0.000% | -3,434,625 (Position Closed) | View |
| 2024-02-02 12:35 pm Sale | 13G | SCPHARMACEUTICALS INC SCPH | Cowen Financial Products LLC | 0 0.000% | -2,407,562 (Position Closed) | View |
| 2024-02-02 12:32 pm Sale | 13G | Project Energy Reimagined Acquisition Corp. PEGR | Cowen Financial Products LLC | 0 0.000% | -1,500,000 (Position Closed) | View |
| 2024-02-02 12:30 pm Unchanged | 13G | LL FLOORING HOLDINGS, INC. LLFLQ | Cowen Financial Products LLC | 1,622,000 5.260% | 0 (Unchanged) | View |
| 2024-02-02 12:28 pm Sale | 13G | Jounce Therapeutics Inc. JNCE | Cowen Financial Products LLC | 0 0.000% | -3,647,430 (Position Closed) | View |